Processing of chromogranins/secretogranin in patients with diabetic retinopathy

Regulatory Peptides

Volumn 167, Issue 1, 2011, Pages

  Fournier, Isabelle ^a,b   Gaucher, David ^a,d   Chich, Jean F ^b,c   Bach, Charlotte ^b   Shooshtarizadeh, Peiman ^b   Picaud, Serge ^d,e,f   Bourcier, Tristan ^a   Speeg Schatz, Claude ^a   Strub, Jean M ^b   Van Dorsselaer, Alain ^b   Corti, Angelo ^g   Aunis, Dominique ^b   Metz Boutigue, Marie H ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INRA Institut National de la Recherche Agronomique   (France)

^d INSTITUT DE LA VISION   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^g SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Chromogranin; Diabetic retinopathy; Neuropeptides; Physiopathology; Proteomics; Secretogranin

Indexed keywords

ALPHA 1 ANTITRYPSIN; CHROMOGRANIN A; CHROMOGRANIN B; SECRETOGRANIN II;

ADULT; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL PROTEOMICS; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEQUENCE ANALYSIS; STRUCTURAL PROTEOMICS; VITREOUS BODY; WESTERN BLOTTING;

AGED; ALPHA 1-ANTITRYPSIN; AMINO ACID SEQUENCE; BLOTTING, WESTERN; CHROMATOGRAPHY, REVERSE-PHASE; CHROMOGRANIN A; CHROMOGRANIN B; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINAL DEGENERATION; SECRETOGRANIN II; SEQUENCE ANALYSIS, PROTEIN; VITREORETINAL SURGERY;

NEWCASTLE DISEASE VIRUS;

EID: 79951683117     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.12.004     Document Type: Article

References (43)

1. Klein R, Klein BE. Vision disorders in diabetes. In: National Diabetes Data Group (ed) Diabetes in America. Bethesda, MD: NIDDKD, National Institutes of Health; 1995, p. 293-338.
2. Adamis A.P., Miller J.W., Bernal M.T., D'Amico D.J., Folkman J., Yeo T.K., Yeo K.T. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994, 118:445-450.
3. Kim S.Y., Johnson M.A., McLeod D.S., Alexander T., Hansen B.C., Lutty G.A. Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes 2005, 54:1534-1542.
4. Lutty G.A., Cao J., McLeod D.S. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 1997, 151:707-714.
5. Maier R., Weger M., Haller-Schober E.M., El-Shabrawi Y., Wedrich A., Theisl A., Aigner R., Barth A., Haas A. Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients. Mol Vis 2008, 14:637-643.
6. Hayasaka S., Zhang X.Y., Cui H.S., Yanagisawa S., Chi Z.L., Hayasaka Y., Shimada Y. Vitreous Chemokines and Sho (Zheng in Chinese) of Chinese-Korean-Japanese medicine in patients with diabetic vitreoretinopathy. Am J Chin Med 2006, 34:537-543.
7. Demircan N., Safran B.G., Soylu M., Ozcan A.A., Sizmaz S. Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy. Eye (Lond) 2006, 20:1366-1369.
8. Taupenot L., Harper K.L., O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 2003, 348:1134-1149.
9. Capellino S., Lowin T., Angele P., Falk W., Grifka J., Straub R.H. Increased chromogranin A levels indicate sympathetic hyperactivity in patients with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 2008, 35:91-99.
10. Zhang D., Lavaux T., Sapin R., Lavigne T., Castelain V., Aunis D., Metz-Boutigue M.H., Schneider F. Serum concentration of chromogranin A at admission: an early biomarker of severity in critically ill patients. Ann Med 2009, 41:38-44.
11. Metz-Boutigue M.H., Garcia-Sablone P., Hogue-Angeletti R., Aunis D. Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 1993, 217:247-257.
12. Tatemoto K., Efendic S., Mutt V., Makk G., Feistner G.J., Barchas J.D. Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 1986, 324:476-478.
13. Gayen J.R., Saberi M., Schenk S., Biswas N., Vaingankar S.M., Cheung W.W., Najjar S.M., O'Connor D.T., Bandyopadhyay G., Mahata S.K. A novel pathway of insulin sensitivity in chromogranin a null mice: a crucial role for pancreastatin in glucose homeostasis. J Biol Chem 2009, 25:25.
14. Curry W.J., McCollum A.P., Brockbank S., Gardiner T.A., Maule A.G., Stitt A.W. Characterisation of WE-14 in porcine ocular tissue. Regul Pept 2003, 113:41-47.
15. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., Marrack P., Mahata S.K., Kappler J.W., Haskins K. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010, 11:225-231.
16. Kahler C.M., Kaufmann G., Kahler S.T., Wiedermann C.J. The neuropeptide secretoneurin stimulates adhesion of human monocytes to arterial and venous endothelial cells in vitro. Regul Pept 2002, 110:65-73.
17. Fischer-Colbrie R., Kirchmair R., Kahler C.M., Wiedermann C.J., Saria A. Secretoneurin: a new player in angiogenesis and chemotaxis linking nerves, blood vessels and the immune system. Curr Protein Pept Sci 2005, 6:373-385.
18. Zhang D., Shooshtarizadeh P., Laventie B.J., Colin D.A., Chich J.F., Vidic J., De Barry J., Chasserot-Golaz S., Delalande F., Van Dorsselaer A., Schneider F., Helle K., Aunis D., Prevost G., Metz-Boutigue M.H. Two chromogranin A-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2. PLoS ONE 2009, 4:e4501.
19. Ortego J., Escribano J., Crabb J., Coca-Prados M. Identification of a neuropeptide and neuropeptide-processing enzymes in aqueous humor confers neuroendocrine features to the human ocular ciliary epithelium. J Neurochem 1996, 66:787-796.
20. Gasnier C., Lugardon K., Ruh O., Strub J.M., Aunis D., Metz-Boutigue M.H. Characterization and location of post-translational modifications on chromogranin B from bovine adrenal medullary chromaffin granules. Proteomics 2004, 4:1789-1801.
21. Gasnier C. New data on structure/function relations of chromogranins and their applications. In. thesis University of Strasbourg; 2006.
22. Lee J.C., Hook V. Proteolytic fragments of chromogranins A and B represent major soluble components of chromaffin granules, illustrated by two-dimensional proteomics with NH(2)-terminal Edman peptide sequencing and MALDI-TOF MS. Biochemistry 2009, 48:5254-5262.
23. Strub J.M., Garcia-Sablone P., Lonning K., Taupenot L., Hubert P., Van Dorsselaer A., Aunis D., Metz-Boutigue M.H. Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614-626 with antibacterial activity. Eur J Biochem 1995, 229:356-368.
24. Elias J.E., Gygi S.P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 2007, 4:207-214.
25. Schmitt S., Linder M., Standker L., Hammes H.P., Preissner K.T. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis. Exp Clin Endocrinol Diabetes 2008, 116:26-34.
26. Lugardon K., Raffner R., Goumon Y., Corti A., Delmas A., Bulet P., Aunis D., Metz-Boutigue M.H. Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A. J Biol Chem 2000, 275:10745-10753.
27. Briolat J., Wu S.D., Mahata S.K., Gonthier B., Bagnard D., Chasserot-Golaz S., Helle K.B., Aunis D., Metz-Boutigue M.H. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A. Cell Mol Life Sci 2005, 62:377-385.
28. Cunha-Vaz J.G. The blood-retinal barriers system. Basic concepts and clinical evaluation. Exp Eye Res 2004, 78:715-721.
29. Soell M., Feki A., Hannig M., Sano H., Pinget M., Selimovic D. Chromogranin A detection in saliva of type 2 diabetes patients. Bosn J Basic Med Sci 2010, 10:2-8.
30. Lorenz K., Troger J., Fischer-Colbrie R., Kremser B., Schmid E., Kralinger M., Teuchner B., Bechrakis N., Kieselbach G. Substance P and secretoneurin in vitreous aspirates of patients with various vitreoretinal diseases. Peptides 2008, 29:1561-1565.
31. Gao B.B., Chen X., Timothy N., Aiello L.P., Feener E.P. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res 2008, 7:2516-2525.
32. Yoshida C., Ishikawa T., Michiue T., Zhao D., Komatsu A., Quan L., Maeda H. Immunohistochemical distribution of chromogranin A in medicolegal autopsy materials. Leg Med (Tokyo) 2009, Suppl 1:S231-S233.
33. Doblinger A., Becker A., Seidah N.G., Laslop A. Proteolytic processing of chromogranin A by the prohormone convertase PC2. Regul Pept 2003, 111:111-116.
34. Biswas N., Rodriguez-Flores J.L., Courel M., et al. Cathepsin L colocalizes with chromogranin a in chromaffin vesicles to generate active peptides. Endocrinology 2009, 150:3547-3557.
35. Laslop A., Weiss C., Savaria D., Eiter C., Seidah Tooze S.A., NG Winkler H. Proteolytic processing of chromogranin B and secretogranin II by prohormone convertases. J Neurochem 1998, 70:374-383.
36. Dillen L., Miserez B., Claeys M., Aunis D., De Potter W. Posttranslational processing of proenkephalins and chromogranins/secretogranins. Neurochem Int 1993, 22:315-352.
37. Parmer R.J., Miles L.A., Xi X.P., Gill B.M., Wu H.J., O'Connor D.T. Processing of chromaffin granule proteins: a profusion of proteases?. Neurochem Int 1993, 22:361-367.
38. Hook V., Funkelstein L., Lu D., Bark S., Wegrzyn J., Hwang S.R. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu Rev Pharmacol Toxicol 2008, 48:393-423.
39. Parmar J.S., Mahadeva R., Reed B.J., Farahi N., Cadwallader K.A. Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 2002, 26:723-730.
40. Ceconi C., Ferrari R., Bachetti T., Opasich C., Volterrani M., Colombo B., Parrinello G., Corti A. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 2002, 23:967-974.
41. Sciola V., Massironi S., Conte D., Caprioli F., Ferrero S., Ciafardini C., Peracchi M., Bardella M.T., Piodi L. Plasma chromogranin a in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:867-871.
42. Heidrich F.M., Zhang K., Estrada M., Huang Y., Giordano F.J., Ehrlich B.E. Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes. Circ Res 2008, 102:1230-1238.
43. Belloni D., Scabini S., Foglieni C., Veschini L., Giazzon A., Colombo B., Fulgenzi A., Helle K.B., Ferrero M.E., Corti A., Ferrero E. The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration. FASEB J 2007, 21:3052-3062.